M. Downs

发表

WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

K. Dellagi, A. Ben Salah, Z. E. Ahmadi, 2009, PLoS neglected tropical diseases.

Enzyme-replacement therapy in life-threatening hypophosphatasia.

Nick Bishop, José Luis Millán, Matthew Downs, 2012, The New England journal of medicine.

Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study.

B. Kosofsky, R. Crystal, P. Slasor, 2018, The Lancet. Child & adolescent health.

WR 279 , 396 , a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis : a phase 2 , randomized , double blind , placebo controlled study

K. Dellagi, Z. E. Ahmadi, A. Salah, 2019 .

Revisiting Co-Trimoxazole Prophylaxis for African Adults in The Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.

T. Taylor, C. Plowe, M. Laufer, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Some practical problems in implementing randomization

J. Wittes, H. Christ-schmidt, K. Tucker, 2010, Clinical trials.

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

J. Buatti, J. Holmlund, J. Wheeler, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome measures to assess efficacy of treatments for age-related macular degeneration.

J. Wittes, M. Downs, 2009, Ophthalmology.

Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and Comprehensibility

Kevin A Buhr, Matthew Downs, Janelle Rhorer, 2018, Therapeutic innovation & regulatory science.

Prolonged survival and tissue trafficking following adoptive transfer of CD 4 z gene-modified autologous CD 4 1 and CD 8 1 T cells in human immunodeficiency virus – infected subjects

D. Scadden, C. June, S. Deeks, 2022 .

Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.

J. Holmlund, N. Dunlap, V. Bar-ad, 2022, International journal of radiation oncology, biology, physics.

Enzyme-replacement therapy in life-threatening hypophosphatasia.

J. Millán, N. Bishop, C. Greenberg, 2012, The New England journal of medicine.